Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1976 Mar;9(3):422–432. doi: 10.1128/aac.9.3.422

In Vitro Activity of BL-S640 Against Gram-Negative Bacilli and Staphylococcus aureus Compared with Activity of Four Other Semisynthetic Cephalosporins

A Vuye *, J Pijck †, H Soep †
PMCID: PMC429547  PMID: 1259401

Abstract

The in vitro activity of BL-S640 (cefatrizine) was determined against 674 recent clinical isolates of Staphylococcus aureus and Enterobacteriaceae. Activity against S. aureus was less than that of cephapirin, cephalothin, and cefazolin, but greater than that of cephalexin. Activity against gram-negative isolates was variable: BL-S640 was slightly less potent than cefazolin against Escherichia coli and Klebsiella, but more active than the other compounds. As for the more resistant gram-negative genera, BL-S640 was significantly superior to the control cephalosporins. The effect of inoculum size on the antibacterial activity was moderate for most organisms except Enterobacter, Providencia stuartii, and indole-positive Proteus, the median minimal inhibitory concentrations of which were 6 to 27 times lower when determined with a 10−4-diluted culture compared with the undiluted one. The stability in aqueous solution at 37 C was remarkably high at the lower pH values, but low at the neutral point.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arret B., Johnson D. P., Kirshbaum A. Outline of details for microbiological assays of antibiotics: second revision. J Pharm Sci. 1971 Nov;60(11):1689–1694. doi: 10.1002/jps.2600601122. [DOI] [PubMed] [Google Scholar]
  2. Axelrod J., Meyers B. R., Hirschman S. Z. Cephapirin: in vitro antibacterial spectrum. Appl Microbiol. 1971 Nov;22(5):904–908. doi: 10.1128/am.22.5.904-908.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. CHANG T. W., WEINSTEIN L. IN VITRO BIOLOGICAL ACTIVITY OF CEPHALOTHIN. J Bacteriol. 1963 May;85:1022–1027. doi: 10.1128/jb.85.5.1022-1027.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. GRIFFITH R. S., BLACK H. R. CEPHALOTHIN--A NEW ANTIBIOTIC. PRELIMINARY CLINICAL AND LABORATORY STUDIES. JAMA. 1964 Sep 14;189:823–828. [PubMed] [Google Scholar]
  5. Griffith R. S., Black H. R. Cephalexin. Med Clin North Am. 1970 Sep;54(5):1229–1244. [PubMed] [Google Scholar]
  6. Leitner F., Buck R. E., Misiek M., Pursiano T. A., Price K. E. BL-S 640, a cephalosporin with a broad spectrum of antibacterial activity: properties in vitro. Antimicrob Agents Chemother. 1975 Mar;7(3):298–305. doi: 10.1128/aac.7.3.298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Sabath L. D., Wilcox C., Garner C., Finland M. In vitro activity of cefazolin against recent clinical bacterial isolates. J Infect Dis. 1973 Oct;128(Suppl):S320–S326. doi: 10.1093/infdis/128.supplement_2.s320. [DOI] [PubMed] [Google Scholar]
  8. Watanakunakorn C., Bannister T., Glotzbecker C. Susceptibility of clinical isolates of Enterobacteriaceae to BL-S640, a new oral cephalosporin. Antimicrob Agents Chemother. 1975 Mar;7(3):381–385. doi: 10.1128/aac.7.3.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Yamana T., Tsuji A., Kanayama K., Nakano O. Comparative stabilities of cephalosporins in aqueous solution. J Antibiot (Tokyo) 1974 Dec;27(12):1000–1002. doi: 10.7164/antibiotics.27.1000. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES